澳门永利官网网址55402|NO.1

About Us

Shenogen Pharma GroupShenogen Pharma Group is a drug discovery and development company founded in 2006 at Beijing, China. Shenogen aims to dev…

News

Beijing Shenogen Pharma Group Ltd. Disclosed the New Findings Related to Icaritin treatment induced Immunomodulation in HCC Tumor Microenvironment

2020 09.25

Cancer Science Online Publication: Phase II Data Demonstrated Clinical Safety and Efficacy of First-in-Class Small Molecule Icaritin in Patients with Advanced HBV-related Hepatocellular Carcinoma

2019 04.12

icaritin phase IIA trial showed favorable safety profiles and preliminary durable survival benefits in advanced HCC patients in BMC Cancer online Publication